FRLN
Income statement / Annual
Last year (2022), Freeline Therapeutics Holdings plc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Freeline Therapeutics Holdings plc's net income was -$88.97 M.
See Freeline Therapeutics Holdings plc,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$1.74 M
|
$2.39 M
|
$1.93 M
|
$1.55 M
|
$0.00
|
Gross Profit |
-$1.74 M
|
-$2.39 M
|
-$1.93 M
|
-$1.55 M
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$66.20 M
|
$95.43 M
|
$76.15 M
|
$47.04 M
|
$34.19 M
|
General & Administrative Expenses |
$30.66 M
|
$44.57 M
|
$26.30 M
|
$16.60 M
|
$6.79 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$30.66 M
|
$44.57 M
|
$26.30 M
|
$16.60 M
|
$6.79 M
|
Other Expenses |
-$1.57 M
|
-$2.09 M
|
-$15.27 M
|
-$10.60 M
|
-$390,000.00
|
Operating Expenses |
$95.29 M
|
$137.91 M
|
$87.18 M
|
$53.05 M
|
$32.72 M
|
Cost And Expenses |
$95.29 M
|
$137.91 M
|
$87.18 M
|
$53.05 M
|
$32.72 M
|
Interest Income |
$904,000.00
|
$403,951.00
|
$275,000.00
|
$74,306.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$151,000.00
|
Depreciation & Amortization |
$1.27 M
|
$9.24 M
|
$17.18 M
|
$12.14 M
|
$970,000.00
|
EBITDA |
-$97.17 M |
-$133.14 M |
-$85.27 M |
-$51.51 M |
-$32.14 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$9.84 M
|
$2.33 M
|
$6.26 M
|
$9.88 M
|
-$470,797.00
|
Income Before Tax |
-$88.60 M
|
-$140.05 M
|
-$96.19 M
|
-$53.77 M
|
-$33.26 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$368,000.00
|
$342,000.00
|
$129,000.00
|
$141,000.00
|
$27,000.00
|
Net Income |
-$88.97 M
|
-$140.39 M
|
-$96.32 M
|
-$53.91 M
|
-$33.28 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
EPS |
-22.52 |
-58.98 |
-102.09 |
-127.39 |
-78.65 |
EPS Diluted |
-22.52 |
-58.98 |
-102.09 |
-127.39 |
-78.65 |
Weighted Average Shares Out |
$3.95 M
|
$2.38 M
|
$943,522.00
|
$423,188.00
|
$423,188.00
|
Weighted Average Shares Out Diluted |
$3.95 M
|
$2.38 M
|
$943,523.00
|
$423,188.00
|
$423,188.00
|
Link |
|
|
|
|
|